Cargando…

The effects of PCB126 on intra-hepatic mechanisms associated with non alcoholic fatty liver disease

BACKGROUND: Non alcoholic fatty liver disease (NAFLD) results from alteration in lipid synthesis and elimination mechanisms such as very-low density lipoprotein (VLDL) production and de novo lipogenesis. Persistent organic pollutants (POPs) are chemicals that were mostly used historically as pestici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boucher, Marie-Pier, Lefebvre, Caroline, Chapados, Natalie Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676123/ https://www.ncbi.nlm.nih.gov/pubmed/26693162 http://dx.doi.org/10.1186/s40200-015-0218-2

Ejemplares similares

Subchronic Exposure to TCDD, PeCDF, PCB126, and PCB153: Effect on Hepatic Gene Expression
por: Vezina, Chad M., et al.
Publicado: (2004)

Metallothionein’s role in PCB126 induced hepatotoxicity and hepatic micronutrient disruption
por: Klaren, W.D, et al.
Publicado: (2015)

Effects of PCB126 on Adipose-to-Muscle Communication in an in Vitro Model
por: Caron, Audrey, et al.
Publicado: (2020)

Toxicogenomic analysis of exposure to TCDD, PCB126 and PCB153: identification of genomic biomarkers of exposure to AhR ligands
por: Ovando, Bladimir J, et al.
Publicado: (2010)

PCB 126 and Other Dioxin-Like PCBs Specifically Suppress Hepatic PEPCK Expression via the Aryl Hydrocarbon Receptor
por: Zhang, Wenshuo, et al.
Publicado: (2012)

Integrated transcriptomics and metabolomics reveal signatures of lipid metabolism dysregulation in HepaRG liver cells exposed to PCB 126
por: Mesnage, Robin, et al.
Publicado: (2018)

Sustained expression of CYPs and DNA adduct accumulation with continuous exposure to PCB126 and PCB153 through a new delivery method: Polymeric implants
por: Aqil, Farrukh, et al.
Publicado: (2014)

Exposure to PCB126 during the nursing period reversibly impacts early-life glucose tolerance
por: Rice, Brittany B., et al.
Publicado: (2023)

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
por: Kawano, Yuki, et al.
Publicado: (2013)

A mode of action-based probabilistic framework of dose-response assessment for nonmutagenic liver carcinogens: a case study of PCB-126
por: Zhou, Yun, et al.
Publicado: (2023)

Absorption of PCB126 by upper airways impairs G protein-coupled receptor-mediated immune response
por: Shimada, Ana Lúcia B., et al.
Publicado: (2015)

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
por: Ipsen, David Højland, et al.
Publicado: (2018)

Lack of Offspring Nrf2 Does Not Exacerbate the Detrimental Metabolic Outcomes Caused by In Utero PCB126 Exposure
por: Rice, Brittany B., et al.
Publicado: (2021)

CYP1A1, VEGFA and Adipokine Responses of Human Adipocytes Co-exposed to PCB126 and Hypoxia
por: Amine, Zeinab El, et al.
Publicado: (2022)

Non‐alcoholic fatty liver disease in patients with autoimmune hepatitis
por: Takahashi, Atsushi, et al.
Publicado: (2018)

Challenges in the hepatic histopathology in non-alcoholic fatty liver disease
por: Brunt, Elizabeth M, et al.
Publicado: (2017)

Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
por: Sanna, Claudia, et al.
Publicado: (2016)

PCB-153 Shows Different Dynamics of Mobilisation from Differentiated Rat Adipocytes during Lipolysis in Comparison with PCB-28 and PCB-118
por: Louis, Caroline, et al.
Publicado: (2014)

The Transcriptional Effects of PCB118 and PCB153 on the Liver, Adipose Tissue, Muscle and Colon of Mice: Highlighting of Glut4 and Lipin1 as Main Target Genes for PCB Induced Metabolic Disorders
por: Mesnier, Aurélia, et al.
Publicado: (2015)

Molecular mechanism of alcoholic fatty liver
por: Rasineni, Karuna, et al.
Publicado: (2012)

Human Preadipocytes Differentiated under Hypoxia following PCB126 Exposure during Proliferation: Effects on Differentiation, Glucose Uptake and Adipokine Profile
por: El Amine, Zeinab, et al.
Publicado: (2023)

Computational Hypothesis: How Intra-Hepatic Functional Heterogeneity May Influence the Cascading Progression of Free Fatty Acid-Induced Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Holzhütter, Hermann-Georg, et al.
Publicado: (2021)

Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease
por: Tong, Xin, et al.
Publicado: (2022)

Novel Ultrasonographic Fatty Liver Indicator Can Predict Hepatitis in Children With Non-alcoholic Fatty Liver Disease
por: Liu, Hsien-Kuan, et al.
Publicado: (2019)

Non-alcoholic Fatty Liver Disease and Liver Fibrosis during Aging
por: Li, Yuan, et al.
Publicado: (2022)

Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease
por: Sun, Chao, et al.
Publicado: (2015)

Biphasic Dose–Response Induced by PCB150 and PCB180 in HeLa Cells and Potential Molecular Mechanisms
por: Zehra, Ainy, et al.
Publicado: (2020)

Cardiovascular Effects of PCB 126 (3,3’,4,4’,5-Pentachlorobiphenyl) in Zebrafish Embryos and Impact of Co-Exposure to Redox Modulating Chemicals
por: Teixidó, Elisabet, et al.
Publicado: (2019)

Inter-observer and Intra-observer Agreement in Pathological Evaluation of Non-alcoholic Fatty Liver Disease Suspected Liver Biopsies
por: Pournik, Omid, et al.
Publicado: (2014)

Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population
por: Ando, Yoshitaka, et al.
Publicado: (2019)

Complete PCB design using OrCAD capture and PCB editor
por: Mitzner, Kraig
Publicado: (2009)

Complete PCB design using OrCAD Capture and PCB Editor
por: Mitzner, Kraig, et al.
Publicado: (2019)

The Vicious Circle of Hepatic Glucagon Resistance in Non-Alcoholic Fatty Liver Disease
por: Galsgaard, Katrine D.
Publicado: (2020)

Role of Hepatic Aryl Hydrocarbon Receptor in Non-Alcoholic Fatty Liver Disease
por: Patil, Nikhil Y., et al.
Publicado: (2023)

In Vitro Cocktail Effects of PCB-DL (PCB118) and Bulky PCB (PCB153) with BaP on Adipogenesis and on Expression of Genes Involved in the Establishment of a Pro-Inflammatory State
por: May, Phealay, et al.
Publicado: (2018)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
por: Fridén, Michael, et al.
Publicado: (2022)

Updating “Dataset of transcriptomic changes that occur in human preadipocytes over a 3-day course of exposure to 3,3′,4,4′,5-Pentachlorobiphenyl (PCB126)” with additional data on exposure to 2,2′,5,5′-tetrachlorobiphenyl (PCB52) or its 4-hydroxy metabolite (4-OH-PCB52)
por: Gourronc, Francoise A., et al.
Publicado: (2023)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Epigenetic Determinants of CYP1A1 Induction by the Aryl Hydrocarbon Receptor Agonist 3,3',4,4',5-Pentachlorobiphenyl (PCB 126)
por: Vorrink, Sabine U., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lsjorc1dcnkdtetq2btq31rtlk